Causality assessment methods in drug induced liver injury: strengths and weaknesses.
about
RUCAM in Drug and Herb Induced Liver Injury: The UpdateHerbal hepatotoxicity: challenges and pitfalls of causality assessment methodsDrug-induced hepatotoxicity: metabolic, genetic and immunological basisDrug- and Herb-Induced Liver Injury in Clinical and Translational Hepatology: Causality Assessment Methods, Quo Vadis?Multicenter study of trimethoprim/sulfamethoxazole-related hepatotoxicity: incidence and associated factors among HIV-infected patients treated for Pneumocystis jirovecii pneumoniaDrug-induced liver injury: recent advances in diagnosis and risk assessment.Current and future directions in the treatment and prevention of drug-induced liver injury: a systematic review.An automated causality assessment algorithm to detect drug-induced liver injury in electronic medical record data.Drug-induced liver injury due to varenicline: a case report.Pregnane X receptor and drug-induced liver injury.Tocilizumab-Induced Acute Liver Injury in Adult Onset Still's DiseaseA challenge for diagnosing acute liver injury with concomitant/sequential exposure to multiple drugs: can causality assessment scales be utilized to identify the offending drug?Reliability of causality assessment for drug, herbal and dietary supplement hepatotoxicity in the Drug-Induced Liver Injury Network (DILIN).Herbal hepatotoxicity in traditional and modern medicine: actual key issues and new encouraging stepsA cross-sectional investigation of chronic exposure to microcystin in relationship to childhood liver damage in the Three Gorges Reservoir Region, China.Population-representative incidence of drug-induced acute liver failure based on an analysis of an integrated health care system.Drug-induced liver injury: results from the hospital-based Berlin Case-Control Surveillance StudyDrug-induced liver injury associated with Complementary and Alternative Medicine: a review of adverse event reports in an Asian community from 2009 to 2014.Drug-Induced Liver Injury Associated with Noni (Morinda citrifolia) Juice and Phenobarbital.Herbalife hepatotoxicity: Evaluation of cases with positive reexposure testsCiprofloxacin Exposure Leading to Fatal Hepatotoxicity: An Unusual Correlation.Drug and herb induced liver injury: Council for International Organizations of Medical Sciences scale for causality assessment.Drug-induced liver injury: the role of drug metabolism and transport.Clinical and causality assessment in herbal hepatotoxicity.Hopes and challenges in using miRNAs as translational biomarkers for drug-induced liver injury.Categorization of drugs implicated in causing liver injury: Critical assessment based on published case reports.A Text Searching Tool to Identify Patients with Idiosyncratic Drug-Induced Liver Injury.Preliminary Results of a Novel Algorithmic Method Aiming to Support Initial Causality Assessment of Routine Pharmacovigilance Case Reports for Medication-Induced Liver Injury: The PV-RUCAM.A nationwide study of the incidence rate of herb-induced liver injury in Korea.Monocyte-derived hepatocyte-like cells for causality assessment of idiosyncratic drug-induced liver injury.Compensation conundrum.Systematic review and meta-analysis of algorithms used to identify drug-induced liver injury (DILI) in health record databases.Agreement Among Different Scales for Causality Assessment in Drug-Induced Liver Injury.Clinical Spectrum and Outcome of Pediatric Drug Induced Liver Injury.Significant Hyperbilirubinemia and Acute Hepatocellular Jaundice in a Pediatric Patient Receiving Deferasirox: A Case Report.Adverse drug reactions in some African herbal medicine: literature review and stakeholders' interview.Suspected herbal hepatotoxicity: requirements for appropriate causality assessment by the US Pharmacopeia.A synergistic effect of Cremophor and beta glucosylceramide to exert liver and sugar protection.
P2860
Q26771817-EF23C31B-6DCD-4972-AA77-B7D93ED4C5B0Q26824747-7CA52DA4-7946-459E-84F1-5C0A6C64AC17Q26991809-8748DB1E-74B3-40AF-A1A7-F09C1FF986F4Q27030822-AB9090BB-BE58-46A4-9B7D-E96AD92FCE7FQ28542714-E5A309B4-A18A-4088-81DB-C7EAC81AD73EQ30235089-6DE3DC35-F14C-47C6-B224-E9D970B6E3B2Q30277969-32D32CE7-45C2-4C54-8F9B-DBBAFFC563F5Q30830530-E750BEBD-8768-4EB3-A1C4-E1D85A5BC824Q34297836-274E104D-DE6B-4EBA-83D7-DDA284020E39Q34345049-AA0A469E-3C62-4F92-8C5D-2D5C73D787A3Q34399037-B162EB73-7B50-48E5-AAF1-5BF46BC64E3BQ34660447-43A024B7-F4BB-4F0A-B95C-0F6F6ADEAEBBQ35009149-585FB1B0-F19E-40B4-9D25-7FBDD564532CQ35531281-E2355427-605C-4384-901F-0771652931CAQ35591849-C00CC347-8FE5-424A-A865-021B0F8D4A5AQ35655664-7BB6AC04-4AFB-4A18-A82E-11A91D815CEAQ35684831-1C4D898F-0000-4074-B36A-FB40B40B5CE4Q36070432-4EF9E0B9-BCA6-46BC-870A-68A6917FD98BQ36613769-37C86BDA-8755-480A-A7BD-C0902C1E8751Q37049109-6A6249BE-BF1A-4641-8A75-4C9E81AB6092Q37282897-DEFF83F7-E9A3-4755-B37F-E57C8F63A91AQ37636570-A232C212-F084-439B-88B4-5D1E4AA1FC7EQ38084215-EF8E1FCE-2F2F-428C-8EA5-8A775C9982E8Q38086300-479BF855-F457-45C7-9CF2-A89984947DFEQ38095111-C0518B25-681F-4ECA-AB07-FF3310D9C46BQ38620305-249ED984-E015-440F-8972-AB4566414E70Q38644395-D6D0A488-EF10-49AC-B7F3-05880F7069ECQ38784195-2995F0F3-CFAB-45AF-8441-876936694389Q40151754-6B920964-0E76-445E-9730-018D25102395Q40867858-00779F82-28A0-419C-9757-AB8857AA46BFQ40970752-64074D15-BB34-48A8-9D35-C3C6D9663F9EQ47386220-2B239725-61D2-41D9-AD0A-9F55525B8884Q47594151-25EBE717-78B9-4129-B937-97DD5B7E33FAQ49787871-B0AE6FC2-FF79-4AE1-A162-C290AF694405Q50321294-B6336029-08B5-4BCD-86B0-2E8322DBA9EFQ51059237-AAEDA20D-978A-4759-940D-52981EEA7758Q51332616-32B9AC30-359F-479C-B650-EEF74F5AD6C5Q55014958-179ECFF4-4A8C-478D-B96A-583A10B05F51
P2860
Causality assessment methods in drug induced liver injury: strengths and weaknesses.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 February 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Causality assessment methods in drug induced liver injury: strengths and weaknesses.
@en
Causality assessment methods in drug induced liver injury: strengths and weaknesses.
@nl
type
label
Causality assessment methods in drug induced liver injury: strengths and weaknesses.
@en
Causality assessment methods in drug induced liver injury: strengths and weaknesses.
@nl
prefLabel
Causality assessment methods in drug induced liver injury: strengths and weaknesses.
@en
Causality assessment methods in drug induced liver injury: strengths and weaknesses.
@nl
P2093
P1476
Causality assessment methods in drug induced liver injury: strengths and weaknesses.
@en
P2093
Alejandra Fernández-Castañer
Camilla Stephens
M Isabel Lucena
Miren García-Cortés
Raúl J Andrade
Spanish Group for the Study of ...... sociadas a Medicamentos GEHAM)
P304
P356
10.1016/J.JHEP.2011.02.007
P577
2011-02-22T00:00:00Z